PTSD and stress disorder
Conditions
Interventions
Patients will be randomized to regular TF-CBT (n = 10) or to TF-CBT +
biofeedback (n = 10). The latter group will receive breathing biofeedback
during all exposure sessions within the TF-CBT treatme
Sponsors
Academisch Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: CAPS score of * 50 Male and female, aged 18 years and above Written informed consent Eligible for exposure therapy Right handed
Exclusion criteria
Exclusion criteria: Suicidal risk Presence of any of the following DSM IV diagnoses, at present or in the past: psychotic disorder incl. schizophrenia, a bipolar disorder, depression with psychotic features, a panic disorder with or without agoraphobia or excessive substance related disorder over the past 6 months Primary diagnosis of severe depressive disorder Presence of primary or co-morbid personality disorder An organic disorder Taking any psychotropic medications at present
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The acute effects of additive biofeedback will be assessed by measuring change in: breathing frequency, heart rate (HR), heart rate variability (HRV), saliva cortisol levels during exposure sessions, and the change on the Subjective Units of Distress (SUDS) during the sessions as well as the change on the Impact of Event Scale-Revised (IES-R) from session to session. Secondary parameters are anxiety and depression rates on the Hospital Anxiety and Depression scale (HADS) from baseline to 1 week post-treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| not applicable. | — |
Countries
Netherlands
Outcome results
None listed